GLP-1

Latest News and Resources

Chart

India Semaglutide Generics Price as Low as $8/Month — 35x Below Novo Nordisk

28 April 2026

Podcast

Combination Product Manufacturing: GLP-1 Hype, Talent Shortages, and the CDMO Shift

20 April 2026

Podcast

Hybrid Synthesis is Redefining Peptide Manufacturing

26 March 2026

Content

FDA’s GLP-1 Crackdown: Regulators Are Turning Up the Heat on Manufacturing Quality

6 March 2026

Expert Insight

Novo Nordisk CEO: We Were ‘Cursed as a Leader’ as Lilly Closes GLP-1 Gap

19 January 2026

Podcast

Simtra BioPharma Solutions CEO Franco Negron on Building Supply Chain Resilience Through Geographic Redundancy

12 January 2026

Manufacturing News

Novo Nordisk wins FDA approval for oral Wegovy, launching first GLP-1 pill for obesity

23 December 2025

Podcast

CordenPharma CEO on Scaling GLP-1 Production and Competing in Complex Modalities

4 December 2025

Manufacturing News

Novo Nordisk, Pfizer Bidding War for Metsera Escalates to $10 Billion as FTC Raises Concerns

6 November 2025

Podcast

Pharma Trends: A Commercial Perspective on Oncology, GLP-1 Expansion, and AI-Accelerated Development

30 October 2025